FindTrial
Sign In

Impact of individualized luteal phase support on reproductive outcomes in GnRH antagonist protocol: a multicenter randomized controlled trial

Impact of individualized luteal phase support on reproductive outcomes in GnRH antagonist protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018274
Enrollment
Unknown
Registered
2018-09-07
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Group 1:GnRH agonist administered on D5 and D8 in addition to traditional luteal phase support
Group 2:traditional luteal phase support
Group 3:GnRH agonist administered on D8 in addition to traditional luteal phase suppor

Sponsors

Beijing Chao-Yang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged 23-35 years; 2. BMI18-28kg/m2; 3. basal FSH=10IU/L; 4. stimulated with GnRH antagonist protocol; 5. more than 2 good embryos on D3.

Exclusion criteria

Exclusion criteria: 1. ultrasound or hysteroscopy indicated intrauterine or endometrial lesion, including endometrial polyp, hyperplasia, intrauterine adhesion, etc; 2. endometriosis, adenomyosis; 3. uterine malformation; 4. submucous myoma and intramural myoma involving endometrium; 5. hydrosalpinx.

Design outcomes

Primary

MeasureTime frame
implantation rate;—

Secondary

MeasureTime frame
clinical pregnancy rate;ongoing pregnancy rate;incidence of OHSS;—

Countries

China

Contacts

Public ContactYuan Li

Beijing Chao-Yang Hospital, Capital Medical University

sdliyuan@126.com+86 010 85231423

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026